Skip to main content
High RiskFDAfda-F-1558-2014OTHER

Cactus Leaves/Pads (Nopales) MexpoGroup Brand MexpoGroup Fresh Produce Colonia Buenos Aires Norte, Tijuana, Baja California, Mexico.

Category
Units Affected
50
Recall Date
January 17, 2014
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1558-2014.

CA Dept of Pesticides tested Cactus pads and found pesticides Monocrotophos at 0.581 ppm, Carbendazim as Thiophanate Methyl at 0.510 ppm and Captan (THPI) at 0.313 ppm. There is no tolerance for these pesticides in the US.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1558-2014.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Rci Produce or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1558-2014.

RCI Produce

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Rci Produce Recall FAQ

Rci Produce is the subject of a produce safety report: Cactus Leaves/Pads (Nopales) MexpoGroup Brand MexpoGroup Fresh Produce Colonia Buenos Aires Norte, Tijuana, Baja California, Mexico.. The notice was published on January 17, 2014 by the U.S. Food and Drug Administration (FDA). Approximately 50 units are potentially affected.